All GLG News Analyses Filed Under: Orthopaedics
Posted May 28, 2007
Learning curve may be longer than thought for placing hip resurfacing components
Analysis of: Learning curve may be longer than thought for placing hip resurfacing components | www.orthosupersite.com
Author: GLG Member Program Contributor
Analysis of: Learning curve may be longer than thought for placing hip resurfacing components | www.orthosupersite.com
Author: GLG Member Program Contributor
This study purports that a greater volume of patients is needed to become proficient and accurate in placing hip resurfacing arthroplasty components; in this procedure patient selection is paramount. Achieving a case volume as listed in the article becomes difficult and performing resurfacing...
Posted May 28, 2007
Emisphere Announces Initiation Of Phase III Clinical Program Of Oral Calcitonin For The Treatment Of Osteoarthritis
Analysis of: Emisphere Announces Initiation Of Phase III Clinical Program Of Oral Calcitonin For The Treatment Of Osteoarthritis | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Analysis of: Emisphere Announces Initiation Of Phase III Clinical Program Of Oral Calcitonin For The Treatment Of Osteoarthritis | www.medicalnewstoday.com
Author: GLG Member Program Contributor
The risks, in monetary terms, are huge. But so are the rewards.
Posted May 23, 2007
FDA Approves Lovenox(R) (enoxaparin Sodium Injection) For The Most Severe Type Of Heart Attack
Analysis of: FDA Approves Lovenox(R) (enoxaparin Sodium Injection) For The Most Severe Type Of Heart Attack | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Analysis of: FDA Approves Lovenox(R) (enoxaparin Sodium Injection) For The Most Severe Type Of Heart Attack | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Lovenox is clearly superior to unfractionated heparin when we look at global costs in the use of anticoagulation. This approval by the FDA gives it one more indication, and allows for simpler anticoagulation treatment.
Posted May 14, 2007
Protelos®: First Osteoporosis Treatment To Show Long-Term, Sustained Efficacy And Quality Of Life Improvement
Analysis of: Protelos®: First Osteoporosis Treatment To Show Long-Term, Sustained Efficacy And Quality Of Life Improvement | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Analysis of: Protelos®: First Osteoporosis Treatment To Show Long-Term, Sustained Efficacy And Quality Of Life Improvement | www.medicalnewstoday.com
Author: GLG Member Program Contributor
With the ability to prevent resorption and promote strong bone formation, this is a unique product. It will clearly assume a major role in th market if administration is easy and the side effect profile is minimal.
Posted May 9, 2007
Pfizer’s Lyrica: On Its way to An Approved Treatment for Fibromyalgia?
Analysis of: Pfizer’s Lyrica cuts fibromyalgia pain in study | www.reuters.com
Author: Louis Sanfilippo, Psychiatrist Louis Sanfilippo, MD
Pfizer’s Lyrica: On Its way to An Approved Treatment for Fibromyalgia?
Analysis of: Pfizer’s Lyrica cuts fibromyalgia pain in study | www.reuters.com
Author: Louis Sanfilippo, Psychiatrist Louis Sanfilippo, MD
While fibromyalgia is not well understood and sometimes conceived of as having psychosomatic contributions, it is estimated to affect up to 2% of the population and still has no FDA approved medication treatments for it.
Previous data on pregabalin (Lyrica; from Pfizer), a novel alpha-2 ligand,...
Posted April 22, 2007
Osteologix Completes Enrollment In Clinical Trial Of Investigational Drug For Osteoporosis
Analysis of: Osteologix Completes Enrollment In Clinical Trial Of Investigational Drug For Osteoporosis | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Analysis of: Osteologix Completes Enrollment In Clinical Trial Of Investigational Drug For Osteoporosis | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Based on available data, there is no reason to think this will be a blockbuster.
Posted March 29, 2007
Wright Medical Group, Inc. Launches the CAROLINA(TM) Jones Fracture System for Foot and Ankle Surgery
Analysis of: Wright Medical Group, Inc. Launches the CAROLINA(TM) Jones Fracture System for Foot and Ankle Surgery | salesandmarketingnetwork.com
Author: GLG Member Program Contributor
Analysis of: Wright Medical Group, Inc. Launches the CAROLINA(TM) Jones Fracture System for Foot and Ankle Surgery | salesandmarketingnetwork.com
Author: GLG Member Program Contributor
Jones fractures are traditionally difficult to manage. Wright Medical has a good range of sizes and lengths of screws. Because of the sizes, style, and lengths of this screws there may be other foot and ankle applications in the future. The percutaneous application will reduce make...
Posted March 26, 2007
Think first about doing a THA procedure in patients with severe hip, low back pain
Analysis of: Think first about doing a THA procedure in patients with severe hip, low back pain | www.orthosupersite.com
Author: GLG Member Program Contributor
Analysis of: Think first about doing a THA procedure in patients with severe hip, low back pain | www.orthosupersite.com
Author: GLG Member Program Contributor
The differential diagnosis of hip and spine has plagued orthopaedic surgeons for some time. Patients often present with both as not only can the pain be linked mechanically there are obvious neurologic reasons for someone with back problems to have referred pain to the hip. Hip arthroplasties...
Posted March 26, 2007
Unigene’s Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis
Analysis of: Unigene’s Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis | home.businesswire.com
Author: GLG Member Program Contributor
Analysis of: Unigene’s Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis | home.businesswire.com
Author: GLG Member Program Contributor
Vertebral compression fractures are a painful and deblilitating problem. We will see an increase as the baby boomers move solidly into clinically significant osteoporosis...Hip fracture also will increase for the same reason....although they do not have a high complication rate if the correct surgery...
Posted March 26, 2007
Impliant Receives CE Mark Approval For The TOPS-on-Fusion(TM) System, The First Integrated Motion Preservation System For Spinal Fusion Patients
Analysis of: Impliant Receives CE Mark Approval For The TOPS-on-Fusion(TM) System, The First Integrated Motion Preservation System For Spinal Fusion Patients | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Previous
Page :
1 2 3 4 5 6 7 8 9 Next61 to
70
of 83Analysis of: Impliant Receives CE Mark Approval For The TOPS-on-Fusion(TM) System, The First Integrated Motion Preservation System For Spinal Fusion Patients | www.medicalnewstoday.com
Author: GLG Member Program Contributor
TOPS is one of a variety of devices designed to maintain motion across a diseased spinal segment. The data published is still quite short of convincing.Inadequate outcome data and reimbursement challenges will be major hurdles for the success of this device in the US market.
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Doctors Say Medication Is Overused in Dementia
www.nytimes.com
Medicare fees to doctors fall Tuesday
news.yahoo.com
FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler
www.investor.jnj.com
Why anaesthetics can make the pain worse
www.newscientist.com
FDA Panel To Weigh Heart Trials For Diabetes Meds
www.pharmalot.com
An illegal use of Lumigan, now legal?
July 3, 2008
How are we to pay for computers with a 10% drop in Medicare fees?
June 30, 2008
Obesity: Higher Healthcare Costs, Lower Productivity
June 26, 2008
Best acne care product I've seen.
June 25, 2008
Jeff is in accounting not a healthcare provider.
June 23, 2008

